0IL8.L

FibroGen, Inc. 0IL8.L

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 0IL8.L 0JW9.L 0HIY.L 0KCC.L 0HX7.L 0L85.L 0YC0.L 0HL9.L 0T6G.L 0IV3.L
6M 45.47 % 20.32 % 176.75 % 35.23 % 104.00 % 0.00 % -93.88 % -99.98 % 80.40 % 3.88 %
YTD -19.96 % -19.64 % 3.73 % 64.50 % 6.55 % 1 120.00 % -94.83 % -99.99 % 3.31 % -63.09 %
1Y 21.90 % -15.73 % 85.64 % 25.41 % -26.43 % 408.33 % -96.00 % -100.00 % -92.41 % -67.79 %
3Y -97.20 % -68.49 % -83.64 % -75.00 % -93.15 % -99.60 % -98.50 % -100.00 % -86.38 % -42.98 %
5Y -97.14 % -96.24 % -42.35 % 37.68 % -92.43 % -99.94 % -99.90 % -99.98 % -98.17 % -22.54 %
10Y -97.14 % -94.91 % -33.63 % 1 776.54 % -92.43 % -99.92 % -99.96 % -99.96 % -99.09 % -33.66 %
From the beginning -97.14 % -94.91 % -33.63 % 1 776.54 % -92.43 % -99.92 % -99.96 % -99.96 % -99.09 % -33.66 %

Dividend

FibroGen, Inc.

Lite Strategy, Inc.

Insight Molecular Diagnostics Inc.

Adicet Bio, Inc.

Affimed N.V.

Q32 Bio Inc.

Geron Corporation